Patent details

EP3570840 Title: COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

Basic Information

Publication number:
EP3570840
PCT Application Number:
US2018014523
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187091921
PCT Publication Number:
WO2018136796
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
French Title of Invention:
COMBINAISONS DU CABOZANTINIB DE DE L'ATÉZOLIZUMAB DESTINÉES AU TRAITEMENT DU CANCER DE LA PROSTATE RÉSISTANT À LA CASTRATION
German Title of Invention:
KOMBINIERUNGEN AUS CABOZANTINIB UND ATEZOLIZUMAB ZUR BEHANDLUNG DER KASTRATION-RESISTANTEN PROSTATAKREBS
SPC Number:

Dates

Filing date:
19/01/2018
Grant date:
19/03/2025
EP Publication Date:
27/11/2019
PCT Publication Date:
26/07/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/03/2025
EP B1 Publication Date:
19/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/01/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/03/2025
 
 

Name:
Exelixis, Inc.
Address:
1851 Harbor Bay Parkway, Alameda, CA 94502, United States (US)

Inventor

1

Name:
SCHEFFOLD, Christian
Address:
United States (US)

2

Name:
HESSEL, Colin
Address:
United States (US)

3

Name:
SCHWAB, Gisela
Address:
United States (US)

Priority

1

Priority Number:
201762448869 P
Priority Date:
20/01/2017
Priority Country:
United States (US)

2

Priority Number:
201762458447 P
Priority Date:
13/02/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/47; A61K 39/39; A61K 9/20; A61K 39/00; A61K 39/395; A61K 45/06; A61P 35/00; A61P 35/04; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202512
Publication date:
19/03/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages